July 1st, 2015 - West Bend, WI, USA -  Spaulding Clinical Research, LLC (SCR), a leading global biopharmaceutical services provider, today announced that the Company had completed an expansion of their Clinical Pharmacology Unit located in West Bend, WI in order to meet growing client demand for expertise-based studies in the early phases of clinical development.

“As biopharmaceutical companies have been conducting more Phase I and Proof-of-Concept studies with increasing complexity, SCR has been well positioned to meet their needs. In this regard, we are a top provider of expertise-based Phase I services and have more than 200 beds, which is among the largest capacities for a single CRO research unit in the world,” said Cassandra Erato, Chief Operating Officer. “With our expansion complete, we are uniquely positioned to provide our customers with a level of flexibility that most units cannot.”

With the most advanced technology; the integration of monitoring, recording, analyzing and reporting all in one place; and a unique specialization in cardiac safety testing for new drugs in development, we provide the highest quality results with the most accurate data and the most efficient procedures in the industry.

At Spaulding Clinical Research, we hold ourselves to the highest standards. Passionate in our pursuit of ingenious solutions that save time and money for our clients and heroic in our ambitions to ensure the health and safety of patients, Spaulding Clinical Research strives to be the Phase I facility by which all others are measured.